Search research articles
Contact Us
Filters
Showing results (51-60 of 121) with videos related to
Page
of 13
Sort By:
Cancer Medicine
|
March 17, 2017
The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia
Daphne Guinn, Amy Lehman, Catherine Fabian, et al.
Blood
|
May 19, 2017
NF-κB p50 (<i>nfkb1</i>) contributes to pathogenesis in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia
Timothy L Chen, Minh Tran, Aparna Lakshmanan, et al.
British Journal of Haematology
|
October 31, 2025
Enitociclib (VIP152), venetoclax and prednisone in relapsed or refractory aggressive non-Hodgkin lymphoma
Max J Gordon, Rahul Lakhotia, Stefania Pittaluga, et al.
Blood
|
March 8, 2011
The role of phosphatidylinositol 3-kinase-δ in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemia
Sarah E M Herman, Rosa Lapalombella, Amber L Gordon, et al.
Leukemia & Lymphoma
|
March 6, 2009
Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma
Kristie A Blum, Mehdi Hamadani, Gary S Phillips, et al.
Blood
|
March 22, 2014
Ibrutinib antagonizes rituximab-dependent NK cell-mediated cytotoxicity
Holbrook E Kohrt, Idit Sagiv-Barfi, Sarwish Rafiq, et al.
The Journal of Clinical Investigation
|
November 21, 2018
PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression
Shuai Dong, Bonnie K Harrington, Eileen Y Hu, et al.
Blood
|
March 23, 2011
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Sarah E M Herman, Amber L Gordon, Erin Hertlein, et al.
Blood
|
September 7, 2013
Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homing
Jason A Dubovsky, Danielle L Chappell, Bonnie K Harrington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2014
Lenalidomide and rituximab for the initial treatment of patients with chronic lymphocytic leukemia: a multicenter clinical-translational study from the chronic lymphocytic leukemia research consortium
Danelle F James, Lillian Werner, Jennifer R Brown, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 121) with videos related to
Sort By:
Page
of 13
Cancer Medicine
|
March 17, 2017
The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia
Daphne Guinn, Amy Lehman, Catherine Fabian, et al.
Blood
|
May 19, 2017
NF-κB p50 (<i>nfkb1</i>) contributes to pathogenesis in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia
Timothy L Chen, Minh Tran, Aparna Lakshmanan, et al.
British Journal of Haematology
|
October 31, 2025
Enitociclib (VIP152), venetoclax and prednisone in relapsed or refractory aggressive non-Hodgkin lymphoma
Max J Gordon, Rahul Lakhotia, Stefania Pittaluga, et al.
Blood
|
March 8, 2011
The role of phosphatidylinositol 3-kinase-δ in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemia
Sarah E M Herman, Rosa Lapalombella, Amber L Gordon, et al.
Leukemia & Lymphoma
|
March 6, 2009
Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma
Kristie A Blum, Mehdi Hamadani, Gary S Phillips, et al.
Blood
|
March 22, 2014
Ibrutinib antagonizes rituximab-dependent NK cell-mediated cytotoxicity
Holbrook E Kohrt, Idit Sagiv-Barfi, Sarwish Rafiq, et al.
The Journal of Clinical Investigation
|
November 21, 2018
PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression
Shuai Dong, Bonnie K Harrington, Eileen Y Hu, et al.
Blood
|
March 23, 2011
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Sarah E M Herman, Amber L Gordon, Erin Hertlein, et al.
Blood
|
September 7, 2013
Lymphocyte cytosolic protein 1 is a chronic lymphocytic leukemia membrane-associated antigen critical to niche homing
Jason A Dubovsky, Danielle L Chappell, Bonnie K Harrington, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 29, 2014
Lenalidomide and rituximab for the initial treatment of patients with chronic lymphocytic leukemia: a multicenter clinical-translational study from the chronic lymphocytic leukemia research consortium
Danelle F James, Lillian Werner, Jennifer R Brown, et al.
Page
of 13